Impact of comorbidity on treatment and prognosis of prostate cancer patients: A population-based study

Critical Reviews in Oncology/Hematology

Volumn 58, Issue 1, 2006, Pages 60-67

  Houterman, S ^a   Janssen Heijnen, M L G ^a   Hendrikx, A J M ^b   Van Den Berg, H A ^b   Coebergh, J W W ^a,c  

^a Eindhoven Cancer Registry   (Netherlands)

^b CATHARINA HOSPITAL   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Comorbidity; Prognosis; Prostate cancer; Treatment

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER SURVIVAL; COMORBIDITY; CONTROLLED STUDY; HUMAN; HUMAN EXPERIMENT; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; PREVALENCE; PROSTATE CANCER; PROSTATECTOMY;

EID: 33644964153     PISSN: 10408428     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.critrevonc.2005.08.003     Document Type: Review

References (18)

1. Visser O, Siesling S, van Dijck JAAM. Incidence of cancer in the Netherlands 1999/2000. Utrecht: Vereniging van Integrale Kankercentra, 2003.
2. M.J. Zelefsky, J. Moughan, J. Owen, A.L. Zietman, M. Roach 3rd, and G.E. Hanks Changing trends in national practice for external beam radiotherapy for clinically localized prostate cancer: 1999 Patterns of Care survey for prostate cancer Int J Radiat Oncol Biol Phys 59 2004 1053 1061
3. C. Mettlin Changes in patterns of prostate cancer care in the United States: results of American College of Surgeons Commission on Cancer studies, 1974-1993 Prostate 32 1997 221 226
4. H.I. Hall, W.A. Satariano, T. Thompson, K.E. Ragland, S.K. Van Den Eeden, and S. Selvin Initial treatment for prostate carcinoma in relation to comorbidity and symptoms Cancer 95 2002 2308 2315
5. L.C. Harlan, A. Potosky, and F.D. Gilliland Factors associated with initial therapy for clinically localized prostate cancer: prostate cancer outcomes study J Natl Cancer Inst 93 2001 1864 1871
6. K.L. Schwartz, S.M. Alibhai, G. Tomlinson, G. Naglie, and M.D. Krahn Continued undertreatment of older men with localized prostate cancer Urology 62 2003 860 865
7. P.N. Post, P.J. Kil, A.J. Hendrikx, M.L. Janssen-Heijnen, M.A. Crommelin, and J.W. Coebergh Comorbidity in patients with prostate cancer and its relevance to treatment choice BJU Int 84 1999 652 656
8. P.N. Post, B.E. Hansen, P.J. Kil, M.L. Janssen-Heijnen, and J.W. Coebergh The independent prognostic value of comorbidity among men aged < 75 years with localized prostate cancer: a population-based study BJU Int 87 2001 821 826
9. M.E. Charlson, P. Pompei, K.L. Ales, and C.R. MacKenzie A new method of classifying prognostic comorbidity in longitudinal studies: development and validation J Chronic Dis 40 1987 373 383
10. UICC. In: TNM atlas illustrated guide to the TNM/pTNM classification of malignant tumours. 4th ed., 2nd revision ed., Berlin: SpringerVerlag; 1992. p. 141-4.
11. T. Hakulinen, and K.H. Abeywickrama A computer program package for relative survival analysis Comput Programs Biomed 19 1985 197 207
12. C.E. Desch, L. Penberthy, and C.J. Newschaffer Factors that determine the treatment for local and regional prostate cancer Med Care 34 1996 152 162
13. D. Scherr, P.W. Swindle, and P.T. Scardino National Comprehensive Cancer Network guidelines for the management of prostate cancer Urology 61 2003 14 24
14. S.M. Alibhai, M.D. Krahn, M.M. Cohen, N.E. Fleshner, G.A. Tomlinson, and G. Naglie Is there age bias in the treatment of localized prostate carcinoma? Cancer 100 2004 72 81
15. P.C. Albertsen, D.G. Fryback, B.E. Storer, T.F. Kolon, and J. Fine The impact of co-morbidity on life expectancy among men with localized prostate cancer J Urol 156 1996 127 132
16. J.F. Piccirillo, R.M. Tierney, I. Costas, L. Grove, and E.L. Spitznagel Jr. Prognostic importance of comorbidity in a hospital-based cancer registry JAMA 291 2004 2441 2447
17. M.J. Barry, P.C. Albertsen, and M.A. Bagshaw Outcomes for men with clinically nonmetastatic prostate carcinoma managed with radical prostactectomy, external beam radiotherapy, or expectant management: a retrospective analysis Cancer 91 2001 2302 2314
18. J.E. Fowler Jr., F.L. Terrell, and D.L. Renfroe Co-morbidities and survival of men with localized prostate cancer treated with surgery or radiation therapy J Urol 156 1996 1714 1718